EdenDx Assay Validated as Supportive Endometrial Cancer Triage Tool in Peer-Reviewed Study
Unlike most cancers, endometrial cancer is rising in incidence and mortality in the U.S., yet there is no population screening program or FDA-cleared noninvasive test to identify it early. Today, Gnosis, a CLIA- and CAP-accredited clinical laboratory, announced a peer-reviewed study in Gynecologic Oncology Reports providing early evidence that the biomarkers behind EdenDx, previously studied predominantly in Asian populations, perform in a...
Read more








